Ma et al. (2020) reported that high PTBP3 expression results in increased resistance to gemcitabine, which is attributed to attenuated autophagy. PTBP3 expression is higher in pancreatic cancer tissues than in corresponding adjacent normal tissues (Ma et al., 2020). The gene discussed is PTBP3; the disease is familial pancreatic carcinoma.